Add Formweb to your mobile device
Approved Formulary
Search results for:
tiZANidine
tiZANidine
Brand names: Zanaflex
| Form | Strength |
|---|---|
| TABLET, ORAL | 4 mg |
Display Centrally Acting Skeletal Muscle Relaxants Class:
122004
Medication comments:
| 2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults. | |
|---|---|
| Medication: | tiZANidine (Zanaflex) |
| Criteria 4: Potentially clinically important drug-drug interactions that should be avoided in older adults. (Table 5) | |
| Interacting drug(s) or class(es) | skeletal muscle relaxants ⇄ CNS-active agents |
| Risk Rationale | Increased risk of falls and of fracture with the concurrent use of ≥3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, Nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants). |
| Recommendation | Avoid concurrent use of ≥3 CNS-active drugs Click for list; minimize the number of CNS-active drugs. |
| Quality of evidence: High, Strength of Recommendation: Strong | |
Last updated: Sep. 19, 2025
- Black Box Warnings Bolded (not boxed): bioequivalence between products
- Look-Alike/Sound-Alike tiZANidine confused with tiaGABine, nizatidine